Skip to main content
main-content
Erschienen in: ästhetische dermatologie & kosmetologie 3/2022

20.06.2022 | Infektionskrankheiten der Haut | CME fortbildung

Bakterielle Infektion der Haut

Pathogenese, Klinik und Therapie des Erysipels

verfasst von: Dr. med. univ. Carina Borst, Dr. med. univ. Dörte Symmank

Erschienen in: ästhetische dermatologie & kosmetologie | Ausgabe 3/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Auszug

Das Erysipel ist eine häufig vorkommende, akut auftretende, bakterielle Infektion der Haut, die oft mit Systemzeichen einhergeht. Diagnostisch ist die Kombination der klassischen klinischen Präsentation und erhöhten Entzündungswerten wegweisend. Nach Antibiotikabehandlung heilt das Erysipel meist komplikationslos ab, allerdings können sich chronisch-rezidivierende Verläufe etablieren.
Literatur
1.
Zurück zum Zitat Cervellin G et al. One holy man, one eponym, three distinct diseases. St. Anthony's fire revisited. Acta Biomed 2020;92:e2021008 Cervellin G et al. One holy man, one eponym, three distinct diseases. St. Anthony's fire revisited. Acta Biomed 2020;92:e2021008
2.
Zurück zum Zitat Paladino ME et al. Erysipelas over the centuries: notes from the history of popes. Intern Emerg Med 2021;16:1727-8 Paladino ME et al. Erysipelas over the centuries: notes from the history of popes. Intern Emerg Med 2021;16:1727-8
3.
Zurück zum Zitat Morris AD. Cellulitis and erysipelas. BMJ Clin Evid 2008;2008:1708 Morris AD. Cellulitis and erysipelas. BMJ Clin Evid 2008;2008:1708
4.
Zurück zum Zitat Sunderkötter C et al. S2k-Leitlinie Haut- und WeichgewebeinfektionenAuszug aus 'Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018'. J Dtsch Dermatol Ges 2019;17:345-71 Sunderkötter C et al. S2k-Leitlinie Haut- und WeichgewebeinfektionenAuszug aus 'Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018'. J Dtsch Dermatol Ges 2019;17:345-71
5.
Zurück zum Zitat Sočan K et al. Trends in the epidemiology of erysipelas in Slovenia. Acta Dermatovenerologica Alpina Pannonica Adriat 2018;27:1-4 Sočan K et al. Trends in the epidemiology of erysipelas in Slovenia. Acta Dermatovenerologica Alpina Pannonica Adriat 2018;27:1-4
6.
Zurück zum Zitat Eriksson B et al. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis 1996;23:1091-8 Eriksson B et al. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis 1996;23:1091-8
7.
Zurück zum Zitat Karakonstantis S. Is coverage of S. aureus necessary in cellulitis/erysipelas? A literature review. Infection 2020;48:183-91 Karakonstantis S. Is coverage of S. aureus necessary in cellulitis/erysipelas? A literature review. Infection 2020;48:183-91
8.
Zurück zum Zitat Cho C Y et al. Group B streptococcal infection in neonates and colonization in pregnant women: an epidemiological retrospective analysis. J Microbiol Immunol Infect 2019;52:265-72 Cho C Y et al. Group B streptococcal infection in neonates and colonization in pregnant women: an epidemiological retrospective analysis. J Microbiol Immunol Infect 2019;52:265-72
9.
Zurück zum Zitat Chiller K et al. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 2001;6:170-4 Chiller K et al. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 2001;6:170-4
10.
Zurück zum Zitat Metzgar D et al. The M protein of group A streptococcus is a key virulence factor and a clinically relevant strain identification marker. Virulence 2011;2:402-12 Metzgar D et al. The M protein of group A streptococcus is a key virulence factor and a clinically relevant strain identification marker. Virulence 2011;2:402-12
11.
Zurück zum Zitat Johansson L et al. Getting under the skin: the immunopathogenesis of streptococcus pyogenes deep tissue infections. Clin Infect Dis 2010;51:58-65 Johansson L et al. Getting under the skin: the immunopathogenesis of streptococcus pyogenes deep tissue infections. Clin Infect Dis 2010;51:58-65
12.
Zurück zum Zitat Brishkoska-Boshkovski V et al. Comorbidities as risk factors for acute and recurrent erysipelas. Open Access Maced J Med Sci 2019;7:937-42 Brishkoska-Boshkovski V et al. Comorbidities as risk factors for acute and recurrent erysipelas. Open Access Maced J Med Sci 2019;7:937-42
13.
Zurück zum Zitat Jendoubi F et al. Intracellular streptococcal uptake and persistence: a potential cause of erysipelas recurrence. Front Med 2019;6:6 Jendoubi F et al. Intracellular streptococcal uptake and persistence: a potential cause of erysipelas recurrence. Front Med 2019;6:6
14.
Zurück zum Zitat Gunderson CG et al. A systematic review of bacteremias in cellulitis and erysipelas. J Infect 2012;64:148-55 Gunderson CG et al. A systematic review of bacteremias in cellulitis and erysipelas. J Infect 2012;64:148-55
15.
Zurück zum Zitat Duvanel T et al. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med 1989;149:293-6 Duvanel T et al. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med 1989;149:293-6
16.
Zurück zum Zitat Raff AB et al. Cellulitis: a review. JAMA 2016;316:325-37 Raff AB et al. Cellulitis: a review. JAMA 2016;316:325-37
17.
Zurück zum Zitat Ren Z et al. Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting. J Am Acad Dermatol 2021;84:1496-503 Ren Z et al. Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting. J Am Acad Dermatol 2021;84:1496-503
18.
Zurück zum Zitat Drerup C et al. Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis. J Dtsch Dermatol Ges 2020;18:1417-24 Drerup C et al. Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis. J Dtsch Dermatol Ges 2020;18:1417-24
19.
Zurück zum Zitat Brishkoska-Boshkovski V et al. Clinical presentation and laboratory characteristics in acute and recurrent erysipelas. Open Access Maced J Med Sci 2019;7:771-4 Brishkoska-Boshkovski V et al. Clinical presentation and laboratory characteristics in acute and recurrent erysipelas. Open Access Maced J Med Sci 2019;7:771-4
20.
Zurück zum Zitat Erturk A et al. The association between serum YKL-40 levels, mean platelet volume, and c reactive protein in patients with cellulitis. Indian J Med Microbiol 2015;33:61-6 Erturk A et al. The association between serum YKL-40 levels, mean platelet volume, and c reactive protein in patients with cellulitis. Indian J Med Microbiol 2015;33:61-6
21.
Zurück zum Zitat Pyo JY et al. Delta neutrophil index contributes to the differential diagnosis between acute gout attack and cellulitis within 24 hours after hospitalization. Rheumatology (Oxford) 2017;56:795-801 Pyo JY et al. Delta neutrophil index contributes to the differential diagnosis between acute gout attack and cellulitis within 24 hours after hospitalization. Rheumatology (Oxford) 2017;56:795-801
22.
Zurück zum Zitat Noh SH et al. Serum procalcitonin level reflects the severity of cellulitis. Ann Dermatol 2016;28:704-10 Noh SH et al. Serum procalcitonin level reflects the severity of cellulitis. Ann Dermatol 2016;28:704-10
23.
Zurück zum Zitat Cox NH et al. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol 2006;155:947-50 Cox NH et al. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol 2006;155:947-50
24.
Zurück zum Zitat Mokni M, Dupuy A, Denguezli M et al (2006) Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study. Dermatology 2006;212:108-12 Mokni M, Dupuy A, Denguezli M et al (2006) Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study. Dermatology 2006;212:108-12
25.
Zurück zum Zitat Björnsdóttir S et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis 2005;41:1416-22 Björnsdóttir S et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis 2005;41:1416-22
26.
Zurück zum Zitat Sapuła M et al. In search of risk factors for recurrent erysipelas and cellulitis of the lower limb: a cross-sectional study of epidemiological characteristics of patients hospitalized due to skin and soft-tissue infections. Interdiscip Perspect Infect Dis 2020:1307232 Sapuła M et al. In search of risk factors for recurrent erysipelas and cellulitis of the lower limb: a cross-sectional study of epidemiological characteristics of patients hospitalized due to skin and soft-tissue infections. Interdiscip Perspect Infect Dis 2020:1307232
27.
Zurück zum Zitat Halpern J et al. Ethnicity and other risk factors for acute lower limb cellulitis: a U.K.-based prospective case-control study. Br J Dermatol 2008;158:1288-92 Halpern J et al. Ethnicity and other risk factors for acute lower limb cellulitis: a U.K.-based prospective case-control study. Br J Dermatol 2008;158:1288-92
28.
Zurück zum Zitat Musette P et al. Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med 2004;15:446-50 Musette P et al. Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med 2004;15:446-50
29.
Zurück zum Zitat Tay EY et al. Cellulitis recurrence score: a tool for predicting recurrence of lower limb cellulitis. J Am Acad Dermatol 2015;72:140-5 Tay EY et al. Cellulitis recurrence score: a tool for predicting recurrence of lower limb cellulitis. J Am Acad Dermatol 2015;72:140-5
30.
Zurück zum Zitat Mrowietz U et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011;303:1-10 Mrowietz U et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011;303:1-10
31.
Zurück zum Zitat Hanifin JM et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001;10:11-8 Hanifin JM et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001;10:11-8
32.
Zurück zum Zitat Fokina EG et al. Prediction degree severity of erysipelas: risk index of hemorrhagic form of erysipelas. J Infect Dis Treat 2016;2:2 Fokina EG et al. Prediction degree severity of erysipelas: risk index of hemorrhagic form of erysipelas. J Infect Dis Treat 2016;2:2
33.
Zurück zum Zitat Rath E et al. Non-purulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort. Infect Dis (Lond) 2020;52:361-71 Rath E et al. Non-purulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort. Infect Dis (Lond) 2020;52:361-71
34.
Zurück zum Zitat Marwick C et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother 2011;66:387-97 Marwick C et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother 2011;66:387-97
35.
Zurück zum Zitat Ibrahim LF et al. Development and validation of a cellulitis risk score: the melbourne ASSET score. Pediatrics 2019;143:e20181420 Ibrahim LF et al. Development and validation of a cellulitis risk score: the melbourne ASSET score. Pediatrics 2019;143:e20181420
36.
Zurück zum Zitat Fitch MT et al. Videos in clinical medicine. Abscess incision and drainage. N Engl J Med 2007;357:e20 Fitch MT et al. Videos in clinical medicine. Abscess incision and drainage. N Engl J Med 2007;357:e20
37.
Zurück zum Zitat Anaya DA et al. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007;44:705-10 Anaya DA et al. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007;44:705-10
38.
Zurück zum Zitat Goh T et al. Early diagnosis of necrotizing fasciitis. Br J Surg 2014;101:e119-25 Goh T et al. Early diagnosis of necrotizing fasciitis. Br J Surg 2014;101:e119-25
39.
Zurück zum Zitat Sundaresan S et al. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol 2017;18:383-390 Sundaresan S et al. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol 2017;18:383-390
40.
Zurück zum Zitat Leitlinie "Diagnostik und Therapie der Venenthrombose und der Lungenembolie". 2019, AWMF-Registernummer 065/002 Leitlinie "Diagnostik und Therapie der Venenthrombose und der Lungenembolie". 2019, AWMF-Registernummer 065/002
41.
Zurück zum Zitat Olson SA et al. Acute compartment syndrome in lower extremity musculoskeletal trauma. J Am Acad Orthop Surg 2005;13:436-44 Olson SA et al. Acute compartment syndrome in lower extremity musculoskeletal trauma. J Am Acad Orthop Surg 2005;13:436-44
42.
Zurück zum Zitat Vandersee S. Erysipelas carcinomatosum. Dtsch Arztebl Int 2019;116:22 Vandersee S. Erysipelas carcinomatosum. Dtsch Arztebl Int 2019;116:22
43.
Zurück zum Zitat Figueras-Nart I et al. Dermatologic and dermatopathologic features of monogenic autoinflammatory diseases. Front Immunol 2019;10:2448 Figueras-Nart I et al. Dermatologic and dermatopathologic features of monogenic autoinflammatory diseases. Front Immunol 2019;10:2448
44.
Zurück zum Zitat Eder S et al. Is compression therapy contraindicated for lower leg erysipelas? : results of a retrospective analysis. Hautarzt 2021;72:34-41 Eder S et al. Is compression therapy contraindicated for lower leg erysipelas? : results of a retrospective analysis. Hautarzt 2021;72:34-41
45.
Zurück zum Zitat Johnson S et al. Can cycloidal vibration plus standard treatment reduce lower limb cellulitis treatment times? J Wound Care 2007;16:166-9 Johnson S et al. Can cycloidal vibration plus standard treatment reduce lower limb cellulitis treatment times? J Wound Care 2007;16:166-9
Metadaten
Titel
Bakterielle Infektion der Haut
Pathogenese, Klinik und Therapie des Erysipels
verfasst von
Dr. med. univ. Carina Borst
Dr. med. univ. Dörte Symmank
Publikationsdatum
20.06.2022
Verlag
Springer Medizin
Erschienen in
ästhetische dermatologie & kosmetologie / Ausgabe 3/2022
Print ISSN: 1867-481X
Elektronische ISSN: 2198-6517
DOI
https://doi.org/10.1007/s12634-022-1667-5